je.st
news
Home
› Biogen Idec's TECFIDERA (Dimethyl Fumarate) Approved In US As A First-Line Oral Treatment For Multiple Sclerosis
Biogen Idec's TECFIDERA (Dimethyl Fumarate) Approved In US As A First-Line Oral Treatment For Multiple Sclerosis
2013-03-27 17:10:00| dairynetwork Home Page
Recently Biogen Idec announced that the U.S. Food and Drug Administration (FDA) has approved TECFIDERA (dimethyl fumarate), a new first-line oral treatment for people with relapsing forms of multiple sclerosis (MS).
Tags: multiple
treatment
approved
oral
Category:Agriculture and Forestry